COMMUNIQUÉS West-GlobeNewswire

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

01/02/2018 - 04:01

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) announced today that it has received a milestone payment from the Company’s Chinese partner for eftilagimod alpha (IMP321), [...]

Sol-Gel Technologies Ltd. Announces Pricing of Initial Public Offering

01/02/2018 - 00:46

NESS ZIONA, Israel, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ: SLGL ), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and [...]

Harvard Bioscience Completes Acquisition of Data Sciences International

01/02/2018 - 00:45

HOLLISTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/02/2018 - 00:30

CAMBRIDGE, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Aviragen Provides New Information Supporting Vote FOR Vaxart Merger

01/02/2018 - 00:15

Reiterates Transaction Represents Best Path Forward for Aviragen and ALL Stockholders CAS Group Has Not Articulated a Clear Plan and Has Now Changed its Stance to Emphasize Teslexivir (BTA074) ATLANTA, Jan. 31, 2018 ( [...]

Novartis announces NEJM publication of updated analysis from ELIANA trial showing longer-term durable remissions with Kymriah(TM) in children, young adults with r/r ALL

31/01/2018 - 23:01

Analysis of 75 patients with median follow-up of more than a year demonstrated an overall remission rate of 81% Event-free survival and overall survival at six months were 73% and 90%, with median duration of remission [...]

MPX Enters Into Management and Option Agreement With Dispensary in Baltimore, Maryland

31/01/2018 - 23:00

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the Company, through its indirect wholly-owned subsidiary, S8 Management, [...]

Kane Biotech Announces Trading on the OTCQB Venture Market

31/01/2018 - 22:47

WINNIPEG, Manitoba, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ), (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), today announced that effective February 1, 2018 shares of the Corporation have [...]

Intellia Therapeutics to Present at February Healthcare Investor Conferences

31/01/2018 - 22:30

CAMBRIDGE, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, will [...]

Golden Leaf Closes Bought Deal Private Placement

31/01/2018 - 22:05

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (the “Company”, “Golden Leaf” or the “Issuer”) (CSE: [...]

Voyager Therapeutics Announces CEO Succession Plan for 2018

31/01/2018 - 22:05

CAMBRIDGE, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]

Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome

31/01/2018 - 22:05

Study 1504 Top-Line Data on Track for 2Q 2018 EMERYVILLE, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous [...]

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

31/01/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 31, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix [...]

Allscripts Names Dennis Olis Chief Financial Officer

31/01/2018 - 22:01

CHICAGO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX ) announced Dennis Olis has been named Chief Financial Officer of the Company, effective January 31, 2018. Since May of 2017 [...]

Nuvectra™ Announces Proposed Follow-On Stock Offering

31/01/2018 - 22:01

PLANO, Texas, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it is commencing an underwritten follow-on public offering of its [...]

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018

31/01/2018 - 22:01

CAMBRIDGE, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]

Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)

31/01/2018 - 22:01

Pediatric NAFLD/NASH is a large and untreated market; provides an opportunity to advance gemcabene in an underserved area with millions of affected patients Proof-of-concept clinical trial expands company’s [...]

AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide (NO) Generator and Delivery System

31/01/2018 - 22:01

First Regulatory Filing for the eNOGenerator System Expected By End of 2018 NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing [...]

IACT Health Selects Alpha Clinical Systems ACS360 eSource Platform for Clinical Trial Data Capture

31/01/2018 - 20:16

COLUMBUS, Ga. and PISCATAWAY, N.J., Jan. 31, 2018 (GLOBE NEWSWIRE) -- IACT Health, a clinical trial management company dedicated to streamlining study operations for highly efficient clinical trials, and Alpha Clinical [...]